Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls
Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS), which is linked to Epstein-Barr virus (EBV) infection, preceding the disease. The molecular mechanisms underlying this connection are only partially understood. We previously described molecular mimi...
Uloženo v:
| Vydáno v: | Proceedings of the National Academy of Sciences - PNAS Ročník 122; číslo 11; s. e2424986122 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
18.03.2025
|
| Témata: | |
| ISSN: | 1091-6490, 1091-6490 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS), which is linked to Epstein-Barr virus (EBV) infection, preceding the disease. The molecular mechanisms underlying this connection are only partially understood. We previously described molecular mimicry between the EBV transcription factor EBV nuclear antigen 1 (EBNA1) and three human CNS proteins: anoctamin-2 (ANO2), alpha-B crystallin (CRYAB), and glial cellular adhesion molecule (GlialCAM). Here, we investigated antibody responses against EBNA1 and GlialCAM in a large cohort of 650 MS patients and 661 matched population controls and compared them to responses against CRYAB and ANO2. We confirmed that elevated IgG responses against EBNA1 and all three CNS-mimic antigens associate with increased MS risk. Blocking experiments confirmed the presence of cross-reactive antibodies and molecular mimicry between EBNA1 and GlialCAM, and accompanying antibody responses against adjacent peptide regions of GlialCAM suggest epitope spreading. Antibody responses against EBNA1, GlialCAM, CRYAB, and ANO2 are elevated in MS patients carrying the main risk allele
and combinations of
with anti-EBNA1 and anti-GlialCAM antibodies increase MS risk significantly and in an additive fashion. In addition, antibody reactivities against more than one EBNA1 peptide and more than one CNS-mimic increase the MS risk significantly but modestly. Overall, we show that molecular mimicry between EBNA1 and GlialCAM is likely an important molecular mechanism contributing to MS pathology. |
|---|---|
| AbstractList | Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS), which is linked to Epstein-Barr virus (EBV) infection, preceding the disease. The molecular mechanisms underlying this connection are only partially understood. We previously described molecular mimicry between the EBV transcription factor EBV nuclear antigen 1 (EBNA1) and three human CNS proteins: anoctamin-2 (ANO2), alpha-B crystallin (CRYAB), and glial cellular adhesion molecule (GlialCAM). Here, we investigated antibody responses against EBNA1 and GlialCAM in a large cohort of 650 MS patients and 661 matched population controls and compared them to responses against CRYAB and ANO2. We confirmed that elevated IgG responses against EBNA1 and all three CNS-mimic antigens associate with increased MS risk. Blocking experiments confirmed the presence of cross-reactive antibodies and molecular mimicry between EBNA1 and GlialCAM, and accompanying antibody responses against adjacent peptide regions of GlialCAM suggest epitope spreading. Antibody responses against EBNA1, GlialCAM, CRYAB, and ANO2 are elevated in MS patients carrying the main risk allele
and combinations of
with anti-EBNA1 and anti-GlialCAM antibodies increase MS risk significantly and in an additive fashion. In addition, antibody reactivities against more than one EBNA1 peptide and more than one CNS-mimic increase the MS risk significantly but modestly. Overall, we show that molecular mimicry between EBNA1 and GlialCAM is likely an important molecular mechanism contributing to MS pathology. Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS), which is linked to Epstein-Barr virus (EBV) infection, preceding the disease. The molecular mechanisms underlying this connection are only partially understood. We previously described molecular mimicry between the EBV transcription factor EBV nuclear antigen 1 (EBNA1) and three human CNS proteins: anoctamin-2 (ANO2), alpha-B crystallin (CRYAB), and glial cellular adhesion molecule (GlialCAM). Here, we investigated antibody responses against EBNA1 and GlialCAM in a large cohort of 650 MS patients and 661 matched population controls and compared them to responses against CRYAB and ANO2. We confirmed that elevated IgG responses against EBNA1 and all three CNS-mimic antigens associate with increased MS risk. Blocking experiments confirmed the presence of cross-reactive antibodies and molecular mimicry between EBNA1 and GlialCAM, and accompanying antibody responses against adjacent peptide regions of GlialCAM suggest epitope spreading. Antibody responses against EBNA1, GlialCAM, CRYAB, and ANO2 are elevated in MS patients carrying the main risk allele HLA-DRB1*15:01, and combinations of HLA-DRB1*15:01 with anti-EBNA1 and anti-GlialCAM antibodies increase MS risk significantly and in an additive fashion. In addition, antibody reactivities against more than one EBNA1 peptide and more than one CNS-mimic increase the MS risk significantly but modestly. Overall, we show that molecular mimicry between EBNA1 and GlialCAM is likely an important molecular mechanism contributing to MS pathology.Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS), which is linked to Epstein-Barr virus (EBV) infection, preceding the disease. The molecular mechanisms underlying this connection are only partially understood. We previously described molecular mimicry between the EBV transcription factor EBV nuclear antigen 1 (EBNA1) and three human CNS proteins: anoctamin-2 (ANO2), alpha-B crystallin (CRYAB), and glial cellular adhesion molecule (GlialCAM). Here, we investigated antibody responses against EBNA1 and GlialCAM in a large cohort of 650 MS patients and 661 matched population controls and compared them to responses against CRYAB and ANO2. We confirmed that elevated IgG responses against EBNA1 and all three CNS-mimic antigens associate with increased MS risk. Blocking experiments confirmed the presence of cross-reactive antibodies and molecular mimicry between EBNA1 and GlialCAM, and accompanying antibody responses against adjacent peptide regions of GlialCAM suggest epitope spreading. Antibody responses against EBNA1, GlialCAM, CRYAB, and ANO2 are elevated in MS patients carrying the main risk allele HLA-DRB1*15:01, and combinations of HLA-DRB1*15:01 with anti-EBNA1 and anti-GlialCAM antibodies increase MS risk significantly and in an additive fashion. In addition, antibody reactivities against more than one EBNA1 peptide and more than one CNS-mimic increase the MS risk significantly but modestly. Overall, we show that molecular mimicry between EBNA1 and GlialCAM is likely an important molecular mechanism contributing to MS pathology. |
| Author | Utz, Paul J Ho, Peggy P Sattarnezhad, Neda Steinman, Lawrence Comanescu, Alexandros I Thomas, Olivia G Kockum, Ingrid Barrett, Alison K Wijeratne, Tilini U Robinson, William H Liu, Yicong Alfredsson, Lars Lanz, Tobias V Olsson, Tomas |
| Author_xml | – sequence: 1 givenname: Neda surname: Sattarnezhad fullname: Sattarnezhad, Neda organization: Department of Neurology, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304 – sequence: 2 givenname: Ingrid orcidid: 0000-0002-0867-4726 surname: Kockum fullname: Kockum, Ingrid organization: Center for Molecular Medicine, Karolinska University Hospital, Stockholm 171 76, Sweden – sequence: 3 givenname: Olivia G orcidid: 0000-0002-2011-1344 surname: Thomas fullname: Thomas, Olivia G organization: Department of Clinical Neuroscience, Therapeutic Immune Design, Center for Molecular Medicine, Karolinska Institute, Stockholm 171 77, Sweden – sequence: 4 givenname: Yicong surname: Liu fullname: Liu, Yicong organization: Center for Molecular Medicine, Karolinska University Hospital, Stockholm 171 76, Sweden – sequence: 5 givenname: Peggy P orcidid: 0000-0002-6848-318X surname: Ho fullname: Ho, Peggy P organization: Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University School of Medicine, Stanford, CA 94305 – sequence: 6 givenname: Alison K surname: Barrett fullname: Barrett, Alison K organization: Institute for Immunity, Transplantation, and Infection, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 – sequence: 7 givenname: Alexandros I surname: Comanescu fullname: Comanescu, Alexandros I organization: Institute for Immunity, Transplantation, and Infection, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 – sequence: 8 givenname: Tilini U surname: Wijeratne fullname: Wijeratne, Tilini U organization: Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 – sequence: 9 givenname: Paul J surname: Utz fullname: Utz, Paul J organization: Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 – sequence: 10 givenname: Lars surname: Alfredsson fullname: Alfredsson, Lars organization: Unit of Occupational Medicine, Institute of Environmental Medicine, Karolinska Institutet, Stockholm 171 77, Sweden – sequence: 11 givenname: Lawrence orcidid: 0000-0002-2437-2250 surname: Steinman fullname: Steinman, Lawrence organization: Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University School of Medicine, Stanford, CA 94305 – sequence: 12 givenname: William H orcidid: 0000-0003-4385-704X surname: Robinson fullname: Robinson, William H organization: The Geriatric Research, Education, and Clinical Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304 – sequence: 13 givenname: Tomas orcidid: 0000-0002-2938-1877 surname: Olsson fullname: Olsson, Tomas organization: Center for Molecular Medicine, Karolinska University Hospital, Stockholm 171 76, Sweden – sequence: 14 givenname: Tobias V orcidid: 0000-0001-7106-8801 surname: Lanz fullname: Lanz, Tobias V organization: Institute for Immunity, Transplantation, and Infection, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40063790$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtPwzAQhC1URB9w5oZ85JKydh6Oj6UqBanABc6V46ypkROH2EHqvycSReI0I803K-3MyaT1LRJyzWDJQKR3XavCkmc8k2XBOD8jMwaSJUUmYfLPT8k8hE8AkHkJF2SaARSpkDAjftVGW_n6SHtUOtpvG49UfSjbhkg39y8rRlVb062zyq1Xz7S2xmCPY0lFDLQZXLSdQxq0w94HG2inoh3zQE3vG3pA5eLhSLVvY-9duCTnRrmAVyddkPeHzdv6Mdm9bp_Wq12ix1diUnDBylykUKZQSERulDK50KoULC0rJjVkNeNYCcFBKA0VG4nCFEZUmqHhC3L7e7fr_deAIe4bGzQ6p1r0Q9inTORSABNyRG9O6FA1WO-73jaqP-7_RuI_YhVs-Q |
| CitedBy_id | crossref_primary_10_1177_13524585251370884 crossref_primary_10_1016_j_msard_2025_106718 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1073/pnas.2424986122 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Sciences (General) |
| EISSN | 1091-6490 |
| ExternalDocumentID | 40063790 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: The Knut and Alice Wallenberg Foundation grantid: n/a – fundername: Swedish Research Council grantid: 2020-01638 – fundername: Swedish Brain Foundation and Horizon Europe grantid: 101137154 – fundername: NIAID NIH HHS grantid: R01 AI173189 – fundername: NIAMS NIH HHS grantid: T32 AR050942 – fundername: NEURO Sweden grantid: n/a – fundername: US Army Medical Research Acquisition Activity grantid: HT9425-23-1-0595 – fundername: Gunvor and Josef Anérs Foundation grantid: n/a – fundername: Stanford School of Medicine Dean's Postdoctoral Fellowship grantid: n/a – fundername: National Institute of Allergy and Infectious Diseases grantid: 1K23AI177932-01A1 |
| GroupedDBID | --- -DZ -~X .55 0R~ 123 2FS 2WC 4.4 5RE 5VS 85S AACGO AAFWJ AANCE ABOCM ABPLY ABPPZ ABTLG ABZEH ACGOD ACIWK ACNCT ACPRK AENEX AFFNX AFHIN AFRAH ALMA_UNASSIGNED_HOLDINGS BKOMP CGR CS3 CUY CVF D0L DIK DU5 E3Z EBS ECM EIF F5P FRP GX1 H13 HH5 JLS JSG KQ8 L7B LU7 N9A NPM N~3 O9- OK1 PNE PQQKQ R.V RHI RNA RNS RPM RXW SJN TAE TN5 UKR WH7 WOQ X7M XSW Y6R YBH YKV YSK ZCA ~02 ~KM 29P 7X8 HYE W8F WOW |
| ID | FETCH-LOGICAL-c498t-62718573083069ee2faaf57ca87138b19c04d12eb77207ac0b1faa6f6f7bc1ef2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 5 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001459431300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1091-6490 |
| IngestDate | Sun Sep 28 08:56:32 EDT 2025 Mon Sep 15 04:48:09 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | molecular mimicry GlialCAM antibodies multiple sclerosis Epstein–Barr virus |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c498t-62718573083069ee2faaf57ca87138b19c04d12eb77207ac0b1faa6f6f7bc1ef2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-0867-4726 0000-0002-6848-318X 0000-0002-2437-2250 0000-0002-2011-1344 0000-0003-4385-704X 0000-0001-7106-8801 0000-0002-2938-1877 |
| OpenAccessLink | https://www.pnas.org/doi/10.1073/pnas.2424986122 |
| PMID | 40063790 |
| PQID | 3175970179 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3175970179 pubmed_primary_40063790 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-03-18 |
| PublicationDateYYYYMMDD | 2025-03-18 |
| PublicationDate_xml | – month: 03 year: 2025 text: 2025-03-18 day: 18 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
| PublicationTitleAlternate | Proc Natl Acad Sci U S A |
| PublicationYear | 2025 |
| SSID | ssj0009580 |
| Score | 2.5025127 |
| Snippet | Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS), which is linked to Epstein-Barr virus (EBV) infection,... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | e2424986122 |
| SubjectTerms | Adult Case-Control Studies Cross Reactions Epstein-Barr Virus Nuclear Antigens - immunology Female Herpesvirus 4, Human - immunology HLA-DRB1 Chains - genetics HLA-DRB1 Chains - immunology Humans Immunoglobulin G - immunology Male Middle Aged Molecular Mimicry - immunology Multiple Sclerosis - diagnosis Multiple Sclerosis - genetics Multiple Sclerosis - immunology Multiple Sclerosis - virology |
| Title | Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40063790 https://www.proquest.com/docview/3175970179 |
| Volume | 122 |
| WOSCitedRecordID | wos001459431300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFA7qePDivi9E8KCHaNpmmuQk4-BycfCgMLchqwxIO5pR8N_7Mk3RiyBIoaeWlte3fE3e-z6ETiC-dFxZIoVykjBPGVFCUUKtZ9Y41hVUz8Qm-GAghkP5kBbcQmqrbHPiLFHb2sQ18otY5ySP_nM5eSVRNSruriYJjXnUKQDKRK_mQ_GDdFc0bAQyIyWTtKX24cXFpFLhPI5GSAE1Pv8dX87qzM3Kf99wFS0nhIl7jUusoTlXraO1FMMBnyai6bMNVPeq6VjX9hMDcjSNjARWz2oMkBFfXw16GVaVxbcv4KP93j1uxVQgKQBAxW0vIg7wHCi244ATS2vAcWoFNzOWnzi1w4dN9HRz_di_I0mAgRiwy5SUOY9UUQXANFpK53KvlO9yo-AvqxA6k4Yym-VOA0SnXBmqM7ii9KXn2mTO51tooaort4OwhUTmlbZMwWEAV9puIZUTOjL0MVPuouPWqCNw8LhroSpXv4fRt1l30XbzZUaTholjxCLC4pLu_eHufbSUR-3e2IsnDlDHQ3i7Q7RoPqbj8HY08xw4Dx7uvwAcnc-r |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibody+reactivity+against+EBNA1+and+GlialCAM+differentiates+multiple+sclerosis+patients+from+healthy+controls&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Sattarnezhad%2C+Neda&rft.au=Kockum%2C+Ingrid&rft.au=Thomas%2C+Olivia+G&rft.au=Liu%2C+Yicong&rft.date=2025-03-18&rft.eissn=1091-6490&rft.volume=122&rft.issue=11&rft.spage=e2424986122&rft_id=info:doi/10.1073%2Fpnas.2424986122&rft_id=info%3Apmid%2F40063790&rft_id=info%3Apmid%2F40063790&rft.externalDocID=40063790 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1091-6490&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1091-6490&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1091-6490&client=summon |